GEN vs TERN · P/E 17, rev $5.00B vs $6.12B cap
Gen Digital Inc. (GEN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GEN and TERN stock pages for the full models.
Not investment advice.